Immunohistochemistry detects mismatch repair gene defects in colorectal cancer

Colorectal Disease

Volumn 8, Issue 5, 2006, Pages 411-417

  Hameed, F ^a   Goldberg, P A ^a,b   Hall, P ^a   Algar, U ^a   van Wijk, R ^a   Ramesar, R ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Medical School   (South Africa)

Author keywords

Colorectal cancer; hMLH1; hMSH2; HNPCC; Immunohistochemistry; Survival

Indexed keywords

GENE PRODUCT; PROTEIN MLH1; PROTEIN MSH2;

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLON BIOPSY; COLON MUCOSA; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MISMATCH REPAIR; MUCINOUS CARCINOMA; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR DIFFERENTIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; CARRIER PROTEINS; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; SURVIVAL ANALYSIS;

EID: 33646411229     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2006.00956.x     Document Type: Article

References (31)

1. Claij N, te Riele H. Microsatellite instability in human cancer: A prognostic marker for chemotherapy? Exp Cell Res 1999;246: 1 -10.
2. Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, Iacopetta B. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 2000;355: 1745 -50.
3. Leach FS, Polyak K, Burrell M et al. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 1996;56: 235 -40.
4. Cawkwell L, Murgatroyd H, Sutherland F et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut 1999; 45: 409 -15.
5. Lindor NM, Burgart LJ, Leontovich O et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20: 1043 -8.
6. StatSoft Inc. (2002) STATISTICA (data analysis software system), Version 6. [WWW document] URL http://www.Statsoft.Com (accessed 2003).
7. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363: 558 -61.
8. Chung DC. The genetic basis of colorectal cancer. insights into critical pathways of tumorigenesis. Gastroenterology 2000;119: 854 -65.
9. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61: 759 -67.
10. Sutherland F, Haine L, Quirke P. Molecular approaches to colorectal cancer. Curr Diagn Pathol 1998;5: 34 -43.
11. Gryfe R, Kim H, Hsieh ETK et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000;342: 69 -77.
12. Gervaz P, Cerottini J-P, Bouzourene H et al. Comparison of microsatellite instability and chromosomal instability in predicting survial of patients with T3N0 colorectal cancer. Surgery 2002;131: 190 -7.
13. Clark AJ, Barnetson R, Farrington SM, Dunlop MG. Prognosis in DNA Mismatch Repair Deficient Colorectal Cancer: Are all MSI Tumours Equivalent? Familial Cancer 2004;3: 85 -91.
14. Liu B, Farrington SM, Petersen GM et al. Genetic instability occurs in the majority of young patients with colorectal cancer. Nature Med 1995;1: 348 -52.
15. Datta RV, LaQuaglia MP, Paty PB. Genetic and phenotypic correlates of colorectal cancer in young patients. N Engl J Med 2000;342: 137 -8.
16. Percesepe A, Borghi F, Menigatti M et al. Molecular screening for hereditary nonpolyposis colorectal cancer: A prospective population-based study. J Clin Oncol 2001; 19: 3944 -50.
17. Herman JG, Umar A, Polyak K et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998;95: 6870 -5.
18. Ward R, Meagher A, Tomlinson I et al. Microsatellite instability and the clinicopathologic features of sporadic colorectal cancer. Gut 2001;48: 821 -9.
19. Marcus VA, Madlensky L, Gryfe R et al. Immunohistochemistry for hMLH1 and hMSH2: A practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999; 23: 1248 -55.
20. Thibodeau SN, French AJ, Roche PC et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996;56: 4836 -40.
21. Thibodeau SN, French AJ, Cunningham JM et al. Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998;58: 1713 -8.
22. Chaves P, Cruz C, Lage P et al. Immunohistochemical detection of mismatch repair gene protein as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol 2000;191: 355 -60.
23. Lukish JR, Muro K, DeNobile J ett al. Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann Surg 1998;227: 51 -6.
24. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994; 145: 148 -56.
25. Alexander J, Watanabe T, Wu T-T, Rashid A, Li S, Hamilton SR. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 2001;158: 527 -35.
26. Ribic CM, Sargent DJ, Moore MJ et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349: 247 -57.
27. Wright CM, Barker M, Newland RC et al. Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer. Br J Surg 2000; 87: 1197 -202.
28. Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res 1998;4: 1 -6.
29. Branch P, Aquilina G, Bignami M, Karran P. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 1993;362: 652 -4.
30. Hemminki A, Mecklin J-P, Järvinen H, Aaltonen LA, Joensuu H. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000; 119: 921 -8.
31. Bras-Goncalves RA, Rosty C, Laurent-Puig P, Soulie P, Dutrillaux B, Poupon M-F. Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status. Br J Cancer 2000; 82: 913 -23.